- MilliporeSigma is investing €62 million in a new quality control building at its Darmstadt headquarters.
- The facility will house 135 employees and is expected to be completed by mid-2025.
MilliporeSigma has announced a €62 million investment in a new quality control building at its Darmstadt headquarters. Scheduled for completion by mid-2025, the nearly 10,000 square meter facility will consolidate approximately 135 employees from various departments into a collaborative, state-of-the-art space. This development is part of a larger investment program, with the company planning to invest around €1.5 billion at the Darmstadt site by 2025.
“Quality plays an essential role in our purpose to impact life and health with science. The quality, compliance and business support are fundamental to our innovative Life Science products, services, and digital offerings and make us a trusted partner to our stakeholders,” said Robert Nass, head of quality and regulatory management, life science business of Merck KGaA. “Our new quality control facility is a reflection of our commitment to deliver the highest quality and safest products to our customers and the patients they serve.”
The new building is designed to meet the German Sustainable Building Council GOLD standard for sustainability. It will feature self-sufficient regenerative energy generation and low-CO2 construction. Additionally, the facility will meet special safety requirements for genetic engineering and biology laboratories, and it will include dust-free labs that adhere to specific hygiene protocols. The laboratories will be GMP-compliant, ensuring high standards of quality and safety.
Darmstadt, Germany, is a critical research and development center for life science technologies within the company. Over the next decade, approximately one-fifth of the life science business’s sales from new products are expected to originate from this location.
Overview of outsourcing trends 
